Elevated central venous pressure is associated with increased mortality in pediatric septic shock patients

Seung Jun Choi1, Eun-Ju Ha1, Won Kyoung Jhang1

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, 388-1 Pungnap-2 dong, Songpa-gu, Seoul, 138-736, Republic of Korea.

BMC Pediatrics
|February 15, 2018
PubMed

Insights

Central venous pressure (CVP) is linked to worse outcomes in pediatric septic shock. Higher CVP levels (>12 mmHg) independently predict mortality in children, highlighting its importance in pediatric intensive care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Hemodynamics
  • Septic Shock Pathophysiology

Background:

  • Central venous pressure (CVP) impacts capillary blood flow and is associated with poor outcomes in adult septic shock.
  • The relationship between CVP and outcomes in pediatric septic shock remains unclear.

Purpose of the Study:

  • To investigate the association between central venous pressure (CVP) and mortality in pediatric septic shock patients.
  • To determine if elevated CVP is an independent risk factor for mortality in this population.

Main Methods:

  • Retrospective analysis of pediatric intensive care unit (PICU) patients with septic shock.
  • Comparison of CVP levels at various time points between survivors and nonsurvivors.
  • Multivariate analysis to identify independent risk factors for mortality.

Main Results:

  • Nonsurvivors had significantly higher initial serum lactic acid, PRISM III scores, VIS, and 6-h CVP compared to survivors.
  • A CVP greater than 12 mmHg was associated with significantly higher mortality rates (50.0%).
  • Elevated CVP (>12 mmHg), high serum lactic acid, and mechanical ventilation were independent predictors of mortality.

Conclusions:

  • Elevated central venous pressure is an independent risk factor for mortality in pediatric septic shock.
  • Monitoring and managing CVP may be crucial for improving outcomes in pediatric septic shock.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
41.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
316